glutathione s transferase alverine RCSB PDB Glutathione S-transferase π: a potential

301, G32G38

The benefits of maintaining healthy levels are numerous, including acute or chronic illnesses such as: Alzheimers disease Cancer Chronic fatigue syndrome Cystic fibrosis Multiple sclerosis Repeated exposure to toxins & heavy metals Inflammatory diseases such as arthritis Cardiovascular disease COPD, asthma, or any chronic breathing problems Chronic stress Anxiety Aging Neurological diseases Viral hepatitis or Cirrhosis Autism

The circular genome map of Burkholderia stagnalis visually illustrates elevated GC content and a uniform distribution of open reading frames (ORFs) (Figure 5b)

The Glutathione industry is valued at US$ 324.6 million in 2025, and is estimated to hit the US$ 585.8 million mark by the year 2032, reflecting an annual growth rate of 8.8%